Paul Andrew Moore

Insider Reports History

Entity
Individual
Location
114 East 4 Th Avenue, Suite 800, Vancouver, British Columbia, Canada
Signature
/s/ Daniel Dex, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul Andrew Moore:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Zymeworks Inc. Chief Scientific Officer Restricted Stock Unit 53K $791K $14.92 Jan 10, 2025 Direct
Zymeworks Inc. Chief Scientific Officer Common Stock 23.3K $348K $14.92 Jan 6, 2025 Direct
Zymeworks Inc. Chief Scientific Officer Stock Option (Right to Buy) 200K Jul 18, 2022 Direct
Zymeworks Inc. Chief Scientific Officer Stock Option (Right to Buy) 79K Jan 10, 2025 Direct

Insider Reports Filed by Paul Andrew Moore

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ZYME Zymeworks Inc. Jan 10, 2025 2 $0 4 Jan 10, 2025 Chief Scientific Officer
ZYME Zymeworks Inc. Jan 6, 2025 6 -$316K 4 Jan 6, 2025 Chief Scientific Officer
ZYME Zymeworks Inc. Jan 5, 2024 6 -$106K 4 Jan 8, 2024 Chief Scientific Officer
ZYME Zymeworks Inc. Jan 5, 2023 2 $0 4 Jan 6, 2023 Chief Scientific Officer
ZYME Zymeworks Inc. Jul 18, 2022 1 $0 4 Jul 19, 2022 Chief Scientific Officer
ZYME Zymeworks Inc. Jul 18, 2022 0 $0 3 Jul 19, 2022 Chief Scientific Officer